Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 14 | 2025 | 211 | 4.210 |
Why?
|
| Caenorhabditis elegans | 11 | 2018 | 19 | 2.960 |
Why?
|
| Calcium Signaling | 7 | 2025 | 49 | 2.940 |
Why?
|
| Calcium | 10 | 2025 | 339 | 2.040 |
Why?
|
| Alzheimer Disease | 4 | 2025 | 280 | 1.890 |
Why?
|
| Caenorhabditis elegans Proteins | 8 | 2018 | 11 | 1.730 |
Why?
|
| Parkinson Disease | 6 | 2025 | 87 | 1.490 |
Why?
|
| Disease Models, Animal | 10 | 2019 | 1083 | 1.330 |
Why?
|
| alpha-Synuclein | 6 | 2018 | 9 | 1.260 |
Why?
|
| Mitochondrial Proteins | 7 | 2023 | 72 | 1.140 |
Why?
|
| Sodium-Calcium Exchanger | 3 | 2022 | 6 | 0.830 |
Why?
|
| Animals, Genetically Modified | 7 | 2018 | 68 | 0.790 |
Why?
|
| Animals | 24 | 2024 | 8199 | 0.770 |
Why?
|
| Parkinson Disease, Secondary | 2 | 2012 | 3 | 0.770 |
Why?
|
| Cell Nucleus | 3 | 2020 | 111 | 0.740 |
Why?
|
| RNA Interference | 5 | 2018 | 78 | 0.710 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 13 | 0.690 |
Why?
|
| Oxidative Stress | 4 | 2024 | 255 | 0.660 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 42 | 0.630 |
Why?
|
| Genes, Helminth | 2 | 2018 | 2 | 0.610 |
Why?
|
| Calcium Channels | 5 | 2025 | 63 | 0.600 |
Why?
|
| Osmotic Pressure | 1 | 2018 | 16 | 0.540 |
Why?
|
| Autophagy | 1 | 2018 | 55 | 0.530 |
Why?
|
| Mitochondrial Membranes | 5 | 2024 | 27 | 0.520 |
Why?
|
| Disease Progression | 1 | 2019 | 591 | 0.520 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 109 | 0.500 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 79 | 0.440 |
Why?
|
| Astrocytes | 2 | 2025 | 61 | 0.430 |
Why?
|
| Microglia | 2 | 2025 | 67 | 0.420 |
Why?
|
| Exoribonucleases | 1 | 2014 | 2 | 0.410 |
Why?
|
| Oxidoreductases | 1 | 2014 | 25 | 0.410 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 124 | 0.390 |
Why?
|
| Environmental Pollutants | 1 | 2012 | 13 | 0.380 |
Why?
|
| Collagen | 1 | 2014 | 229 | 0.370 |
Why?
|
| Bacopa | 1 | 2011 | 1 | 0.350 |
Why?
|
| Antiparkinson Agents | 1 | 2011 | 10 | 0.350 |
Why?
|
| Cytoprotection | 1 | 2011 | 9 | 0.350 |
Why?
|
| Sirtuins | 1 | 2011 | 21 | 0.340 |
Why?
|
| Neuroprotective Agents | 1 | 2011 | 32 | 0.340 |
Why?
|
| Pesticides | 1 | 2012 | 135 | 0.340 |
Why?
|
| Plant Extracts | 1 | 2011 | 61 | 0.330 |
Why?
|
| Humans | 18 | 2025 | 32284 | 0.330 |
Why?
|
| Caloric Restriction | 1 | 2011 | 92 | 0.320 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 729 | 0.310 |
Why?
|
| Reactive Oxygen Species | 6 | 2024 | 163 | 0.300 |
Why?
|
| Ubiquitin | 2 | 2020 | 15 | 0.300 |
Why?
|
| Mice, Knockout | 5 | 2023 | 454 | 0.280 |
Why?
|
| Mice | 8 | 2023 | 2571 | 0.270 |
Why?
|
| Neurons | 2 | 2024 | 486 | 0.270 |
Why?
|
| Lipid Metabolism | 2 | 2019 | 108 | 0.270 |
Why?
|
| Gene Expression Regulation | 3 | 2025 | 478 | 0.250 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2025 | 38 | 0.220 |
Why?
|
| Cell Line | 1 | 2025 | 454 | 0.220 |
Why?
|
| Oligodendroglia | 1 | 2024 | 5 | 0.210 |
Why?
|
| Pericytes | 1 | 2024 | 32 | 0.200 |
Why?
|
| MicroRNAs | 1 | 2025 | 181 | 0.190 |
Why?
|
| Myocytes, Cardiac | 2 | 2022 | 90 | 0.190 |
Why?
|
| Dopamine | 3 | 2015 | 262 | 0.190 |
Why?
|
| Endothelial Cells | 1 | 2024 | 193 | 0.190 |
Why?
|
| Proteomics | 1 | 2023 | 97 | 0.180 |
Why?
|
| Acetylcholine | 3 | 2018 | 69 | 0.170 |
Why?
|
| Energy Metabolism | 2 | 2019 | 153 | 0.170 |
Why?
|
| Atrial Fibrillation | 2 | 2016 | 410 | 0.170 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 16 | 0.170 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2020 | 5 | 0.170 |
Why?
|
| JC Virus | 1 | 2020 | 20 | 0.160 |
Why?
|
| Second Messenger Systems | 1 | 2020 | 8 | 0.160 |
Why?
|
| Electron Transport | 1 | 2020 | 16 | 0.160 |
Why?
|
| Sodium | 1 | 2020 | 41 | 0.160 |
Why?
|
| Protein Folding | 1 | 2020 | 31 | 0.160 |
Why?
|
| Unfolded Protein Response | 1 | 2020 | 15 | 0.160 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 23 | 0.160 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 17 | 0.150 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2019 | 19 | 0.150 |
Why?
|
| Neuroblastoma | 1 | 2019 | 32 | 0.150 |
Why?
|
| Apoptosis | 2 | 2025 | 375 | 0.150 |
Why?
|
| Oxidopamine | 2 | 2025 | 24 | 0.140 |
Why?
|
| Heart Atria | 2 | 2016 | 81 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2019 | 80 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 315 | 0.140 |
Why?
|
| Spermidine | 1 | 2018 | 2 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2019 | 243 | 0.140 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 10 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 32 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2019 | 461 | 0.130 |
Why?
|
| RNA | 1 | 2018 | 94 | 0.130 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 3 | 2023 | 10 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 3 | 2023 | 48 | 0.120 |
Why?
|
| Phenylenediamines | 1 | 2016 | 2 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 20 | 0.120 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2016 | 5 | 0.120 |
Why?
|
| Melanins | 1 | 2016 | 7 | 0.120 |
Why?
|
| Longevity | 2 | 2018 | 23 | 0.120 |
Why?
|
| Chromones | 1 | 2015 | 6 | 0.120 |
Why?
|
| Alkaloids | 1 | 2015 | 9 | 0.120 |
Why?
|
| Locomotion | 1 | 2015 | 34 | 0.120 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2015 | 24 | 0.120 |
Why?
|
| Protein Transport | 1 | 2015 | 80 | 0.120 |
Why?
|
| Staining and Labeling | 1 | 2015 | 63 | 0.110 |
Why?
|
| Heart Conduction System | 1 | 2016 | 76 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 65 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 466 | 0.110 |
Why?
|
| Heart Failure | 1 | 2022 | 728 | 0.110 |
Why?
|
| Receptor, Insulin | 1 | 2014 | 9 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2015 | 727 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2014 | 17 | 0.110 |
Why?
|
| Chalcones | 1 | 2014 | 3 | 0.110 |
Why?
|
| Benzofurans | 1 | 2014 | 3 | 0.110 |
Why?
|
| Chalcone | 1 | 2014 | 3 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 23 | 0.110 |
Why?
|
| Piperidines | 1 | 2015 | 137 | 0.110 |
Why?
|
| Thiophenes | 1 | 2014 | 24 | 0.110 |
Why?
|
| Lipids | 1 | 2015 | 253 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 111 | 0.100 |
Why?
|
| RNA, Double-Stranded | 1 | 2014 | 6 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2014 | 50 | 0.100 |
Why?
|
| Antioxidants | 1 | 2014 | 122 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2014 | 88 | 0.100 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2025 | 20 | 0.100 |
Why?
|
| Oxidative Phosphorylation | 2 | 2025 | 30 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 792 | 0.100 |
Why?
|
| Brain | 1 | 2019 | 965 | 0.090 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 12 | 0.090 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2012 | 27 | 0.090 |
Why?
|
| Phenotype | 1 | 2014 | 622 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 423 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 595 | 0.080 |
Why?
|
| Female | 4 | 2019 | 19947 | 0.080 |
Why?
|
| Hela Cells | 2 | 2019 | 72 | 0.070 |
Why?
|
| Acetylcholinesterase | 2 | 2018 | 18 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2018 | 193 | 0.060 |
Why?
|
| Rotenone | 1 | 2025 | 4 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2025 | 38 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 93 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2022 | 29 | 0.040 |
Why?
|
| Ventricular Remodeling | 1 | 2022 | 63 | 0.040 |
Why?
|
| Dimerization | 1 | 2020 | 30 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2020 | 20 | 0.040 |
Why?
|
| Virus Replication | 1 | 2020 | 42 | 0.040 |
Why?
|
| Chemical Precipitation | 1 | 2020 | 1 | 0.040 |
Why?
|
| Membrane Fluidity | 1 | 2020 | 2 | 0.040 |
Why?
|
| Calcium Phosphates | 1 | 2020 | 9 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 71 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2020 | 111 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2019 | 5 | 0.040 |
Why?
|
| Glycolysis | 1 | 2019 | 17 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 16 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 31 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 9 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2019 | 59 | 0.040 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 6 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 24 | 0.040 |
Why?
|
| Fibrosis | 1 | 2019 | 126 | 0.040 |
Why?
|
| Zebrafish | 1 | 2019 | 23 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2019 | 34 | 0.040 |
Why?
|
| Cardiolipins | 1 | 2018 | 3 | 0.040 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2018 | 8 | 0.040 |
Why?
|
| Myocardium | 1 | 2019 | 184 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2019 | 144 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2018 | 58 | 0.030 |
Why?
|
| Male | 3 | 2020 | 19443 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2018 | 9 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 112 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 290 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 244 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2018 | 100 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 264 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2018 | 131 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 274 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 839 | 0.030 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2016 | 2 | 0.030 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2016 | 5 | 0.030 |
Why?
|
| Dogs | 1 | 2016 | 126 | 0.030 |
Why?
|
| Benzamides | 1 | 2016 | 60 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 1895 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2016 | 76 | 0.030 |
Why?
|
| Adipocytes | 1 | 2016 | 69 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 79 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2016 | 99 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2015 | 19 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2015 | 66 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 757 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2015 | 41 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 237 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 11 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 288 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 70 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 87 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2014 | 87 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 112 | 0.030 |
Why?
|
| Binding Sites | 1 | 2014 | 144 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 246 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 762 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 346 | 0.020 |
Why?
|
| Motor Activity | 1 | 2014 | 332 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 390 | 0.020 |
Why?
|